Brainstorm Cell (Germany) Probability of Future Stock Price Finishing Over 11.56
| GHDN Stock | EUR 2.69 0.00 0.00% |
Brainstorm |
Brainstorm Cell Target Price Odds to finish over 11.56
The tendency of Brainstorm Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move over € 11.56 or more in 90 days |
| 2.69 | 90 days | 11.56 | close to zero percent |
Based on a normal probability distribution, the odds of Brainstorm Cell to move over € 11.56 or more in 90 days from now is close to zero percent (This Brainstorm Cell Therapeutics probability density function shows the probability of Brainstorm Stock to fall within a particular range of prices over 90 days) . Probability of Brainstorm Cell Ther price to stay between its current price of € 2.69 and € 11.56 at the end of the 90-day period is about 72.9 .
Assuming the 90 days trading horizon Brainstorm Cell Therapeutics has a beta of -0.49. This usually indicates as returns on the benchmark increase, returns on holding Brainstorm Cell are expected to decrease at a much lower rate. During a bear market, however, Brainstorm Cell Therapeutics is likely to outperform the market. Additionally Brainstorm Cell Therapeutics has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial. Brainstorm Cell Price Density |
| Price |
Predictive Modules for Brainstorm Cell
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Brainstorm Cell Ther. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Brainstorm Cell Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Brainstorm Cell is not an exception. The market had few large corrections towards the Brainstorm Cell's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Brainstorm Cell Therapeutics, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Brainstorm Cell within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | -0.56 | |
β | Beta against Dow Jones | -0.49 | |
σ | Overall volatility | 0.41 | |
Ir | Information ratio | -0.22 |
Brainstorm Cell Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Brainstorm Cell for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Brainstorm Cell Ther can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Brainstorm Cell Ther is not yet fully synchronised with the market data | |
| Brainstorm Cell Ther generated a negative expected return over the last 90 days | |
| Brainstorm Cell Ther has high financial leverage indicating that it may have difficulties to generate enough cash to satisfy its financial obligations | |
| Brainstorm Cell Therapeutics has accumulated 3.04 M in total debt with debt to equity ratio (D/E) of 934.0, indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Brainstorm Cell Ther has a current ratio of 0.95, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due. Debt can assist Brainstorm Cell until it has trouble settling it off, either with new capital or with free cash flow. So, Brainstorm Cell's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Brainstorm Cell Ther sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Brainstorm to invest in growth at high rates of return. When we think about Brainstorm Cell's use of debt, we should always consider it together with cash and equity. | |
| Net Loss for the year was (24.46 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Brainstorm Cell Therapeutics has accumulated about 6.22 M in cash with (26.27 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.29. | |
| Roughly 23.0% of Brainstorm Cell shares are held by company insiders |
Brainstorm Cell Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Brainstorm Stock often depends not only on the future outlook of the current and potential Brainstorm Cell's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Brainstorm Cell's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 36.3 M |
Brainstorm Cell Technical Analysis
Brainstorm Cell's future price can be derived by breaking down and analyzing its technical indicators over time. Brainstorm Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Brainstorm Cell Therapeutics. In general, you should focus on analyzing Brainstorm Stock price patterns and their correlations with different microeconomic environments and drivers.
Brainstorm Cell Predictive Forecast Models
Brainstorm Cell's time-series forecasting models is one of many Brainstorm Cell's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Brainstorm Cell's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about Brainstorm Cell Ther
Checking the ongoing alerts about Brainstorm Cell for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Brainstorm Cell Ther help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Brainstorm Cell Ther is not yet fully synchronised with the market data | |
| Brainstorm Cell Ther generated a negative expected return over the last 90 days | |
| Brainstorm Cell Ther has high financial leverage indicating that it may have difficulties to generate enough cash to satisfy its financial obligations | |
| Brainstorm Cell Therapeutics has accumulated 3.04 M in total debt with debt to equity ratio (D/E) of 934.0, indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Brainstorm Cell Ther has a current ratio of 0.95, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due. Debt can assist Brainstorm Cell until it has trouble settling it off, either with new capital or with free cash flow. So, Brainstorm Cell's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Brainstorm Cell Ther sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Brainstorm to invest in growth at high rates of return. When we think about Brainstorm Cell's use of debt, we should always consider it together with cash and equity. | |
| Net Loss for the year was (24.46 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Brainstorm Cell Therapeutics has accumulated about 6.22 M in cash with (26.27 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.29. | |
| Roughly 23.0% of Brainstorm Cell shares are held by company insiders |
Additional Information and Resources on Investing in Brainstorm Stock
When determining whether Brainstorm Cell Ther offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Brainstorm Cell's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Brainstorm Cell Therapeutics Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Brainstorm Cell Therapeutics Stock:Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. You can also try the Sign In To Macroaxis module to sign in to explore Macroaxis' wealth optimization platform and fintech modules.